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Abstract

CANNABINOID MODULATION OF HIV-1 TAT-STIMULATED ADHESION OF
MACROPHAGE-LIKE CELLS TO THE EXTRACELLULAR MATRIX
By Johnathan A. Drevik, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2013.
Major Director: Guy A. Cabral, Ph.D.
Professor, Department of Microbiology and Immunology

HIV-Associated Neurocognitive Disorders (HANDs) are becoming one of the
largest problems in patients infected with HIV-1. The ability of infected cells such as
monocytes and microglial cells to act as viral reservoirs causes extreme inflammation in
the CNS and has led to several different types of neurocognitive problems. Specifically
these HIV-1 infected monocytes are able to secrete inflammatory factors such as the
regulatory protein Tat which acts as a chemoattractant for monocytes while also promoting
the adhesion of leukocytes to the extracellular matrix (ECM).
We have shown that one of the major features of the Tat protein is that it promotes
cytoskeletal rearrangement resulting in increased adhesion. Specifically integrin and actin
viii

visualization was performed using confocal immunofluorescence while cytoskeletal
morphology was shown with light and SEM. This microscopy work showed the Tat
protein resulted in altered β1-integrin expression and distribution as well as changes in
polymerized actin. These cytoskeletal changes resulted in increased adhesion to the ECM.
Similarly we have also shown that these cytoskeletal changes of β1-integrin distribution
and polymerized actin can be modulated through select cannabinoids THC and CP55940
that bind through the CB2 receptor which inhibits this adhesion as well as the
morphological changes. The modulation of this reorganization is characteristic of a signal
transduction pathway where a novel convergent point between extracellular Tat and the
select cannabinoids THC and CP55940 exists. The aim of this project was to show the
cytoskeletal reorganization using different microscopy techniques including light and
scanning electron microscopy. This was followed by identifying and characterizing the
convergent point along the signal transduction pathway linked to these changes. Different
techniques were utilized in order to identify the putative convergent point in the signal
transduction cascade including antibody arrays, RT-PCR, and western immunoblotting.
The cytoskeletal rearrangements of β1-integrin and actin polymerization were
shown successfully via light and scanning electron microscopy in the context of treatment
with Tat in the presence and absence of select cannabinoids THC and CP55940. Several
different pathways were identified as possibly linked to cannabinoid-mediated inhibition of
signal transductional activation consequent of attachment to extracellular matrix proteins.
However, the exact molecules implicated in specific signal transductional pathways as
targets of cannabinoid-mediated action remain to be defined.
ix

Introduction

Due to the application of highly active antiretroviral therapy (HAART), the
survival rate of patients diagnosed with HIV infection has increased. However, although
the viral load in these patients has decreased, there is one problem that remains-- the
development HIV-Associated Neurocognitive Disorders (HAND) (Strazza et al., 2011).
Cognitive impairment occurs in a substantial number (15-50%) of HIV-infected patients
(Goodkin et al., 1995). There are three classifications of HAND, HIV-associated dementia
(HAD), minor cognitive motor disorder, and asymptomatic neurocognitive impairment. Of
those infected with HIV-1, approximately 15% develop HAD and 30 to 60% develop less
severe forms of HAND (Gendelman et al., 2005; McArthur, 2004). Due to the longevity of
patient life through HAART the prevalence of milder HAND has increased (Ances et al.,
2008). While the pathological mechanisms underlying HAND are unknown, studies
suggest that HIV-specified proteins, as well as advanced age and co-morbid
neurodegenerative disease, act together resulting in the clinical presentation of this disorder
(Ghafouri et al., 2006). It is thought that HIV-1 enters the CNS through transmigration of
virally-infected leukocytes early in the infection. These infected macrophages secrete
chemokines, cytokines, and toxic viral proteins such as trans-activating protein (Tat) and
gp120 which compromise the integrity of the blood brain barrier (BBB). Through
10

disruption of the blood brain barrier toxic viral proteins gain access to the CNS through
different modes. Clinical manifestations associated with HAND include, impaired mental
concentration, slowness of hand movements, and difficulty walking. The immunological
pathologies include widespread reactive astrocytosis, myelin pallor, as well as infiltration
of blood-derived macrophages, resident microglia, and multinucleated giant cells. (Lipton
et al., 1995).
One issue with retroviral therapy is that, in spite of HAART treatment, certain
proteins may be secreted by the virus-infected cells that can still act on neighboring cells.
HIV-infected macrophages have been shown to secrete chemokines, cytokines, and viral
products that include the HIV-1 Trans-activator of Transcription (Tat) protein (Ensoli et
al., 1993). The Tat protein can interact with neighboring cells in two ways, extracellular
Tat may be taken up by cells and enter the nucleus and alter gene regulation or it can
interact with cell receptors on the surface (Albini et al., 1996). The extracellular Tat
protein can cause an inflammatory response in the CNS through increased production of
proinflammatory cytokines, chemokines, and adhesion molecules (Conant et al., 1998;
Dallasta et al., 1999). The Tat protein has been detected in the serum, blood and cerebral
spinal fluid (CSF) of HIV-1 infected individuals (Nath et al., 1998a). The Tat protein has
been detected at a concentration of 16 ng/mL in the CSF, 0.1-1nM in the blood and at
concentrations of 1-3 ng/mL in serum (Westendorp et al., 1995; Nath et al., 1998a). There
are several neurotoxic actions of extracellular Tat that include, but are not limited to,
depolarization of neurons, increased levels of intracellular calcium, increased
production/release of pro-inflammatory cytokines, increased macrophage infiltration,
11

activation of excitatory amino acid receptors, and increased apoptosis (Nath et al., 1998b;
New et al., 1997; Chang et al., 1997).
Most regimens of retroviral therapy (RT) utilize nucleoside analog reverse
transcriptase inhibitors (NRTIs), that consist of two NRTIs as well as a protease inhibitor
(PI) (Dybul et al., 2002). However, Tat is not responsive to the action of protease and
deoxynucleoside inhibitors. Because the Tat protein is not responsive to HAART, it can
cause inflammation in the brain. Therefore, by treating the inflammatory process caused by
extracellular Tat, a much more complete regimen for HIV could be used to treat HAND.
The gene for Tat is comprised of two exons, one in the central region of the
proviral genome making up the most conserved portion of the protein (amino acids 1-72),
and the other overlaping the envelope gene. The spliced tat mRNA is translated into an 86101 amino acid protein that transactivates proviral transcription through interaction with
the RNA hairpin as well as conditioning the functioning of the LTR-driven transcription
complex (Marzio et al., 1998). The Tat protein has distinct domains, an N-terminal domain
(amino acids 1-20), a cysteine rich (amino acids 21-40), a core domain (amino acids 4148), a basic domain (amino acids 49-72), and a C-terminal domain (amino acids 73-101)
(Fig. 1). The C-terminal domain also contains an Arginine-Glycine-Aspartic Acid (RGD)
motif which is typical of extracellular matrix proteins (Jones et al., 1994). This RGD
domain is known as the key site for integrin receptor adhesion (Brake et al., 1990).
There are several functions elicited by the Tat protein, one of which is the induction
of chemokine and cytokine production. Extracellular Tat then will activate neighboring
cells triggering more chemokine and cytokine production (D'Aversa et al., 2004); (Eugenin
12

et al., 2005). One of the major features of the Tat protein is molecular mimicry to
components that bind extracellular matrix proteins. The protein has this ability due to two
functional regions, the basic domain which binds basic fibroblast growth factor (bFGF)
from heparin sulfate proteoglycans (Barillari et al., 1999a; Barillari et al., 1999b; Chang et
al., 1997) and the RGD region which binds the α5β1 and αVβ3 integrins (Barillari et al.,
1993). Extracellular Tat protein alters adhesion through the use of three different receptors:
integrins, VEGF receptors, and chemokine receptors. The protein does this by binding to
receptors and inducing inflammatory genes as well as activating the universal
transcriptional factor nuclear factor- kB (NF-kB) (Conant et al., 1998). Activated NF-kB
then activates transcription of genes involved in cytokine and chemokine production as
well as that of adhesion molecules (Barnes, 1997).
The Tat protein also has been shown to have effects on primary human brain
microvascular endothelial cells (HBMECs) that result in HIV-associated dementia (HAD).
Tat alters, the permeability of the blood brain barrier (BBB), through the interaction with
HBMECs, resulting in infiltration of infected and uninfected monocytes into the CNS
(Avraham et al., 2004). Upon treatment of monocytes with Tat protein an upregulation in
β1-integrins, extracellular matrix proteins used for attachment and signal transduction, was
shown in a monocyte-derived cell line (Lafrenie et al., 1996). This upregulation was
associated with enhanced monocyte adhesion to cytokine activated endothelial layers
(Cavender et al., 1991). In fact, it has been shown that HIV Tat-treated monocytes
synthesize three times more β1-integrins than untreated cells (Lafrenie et al., 1996). Once
these primary monocytes are bound, it has been shown that Tat1-72 can stimulate monocyte
13

entry into the brain (Pu et al., 2003). These infected monocytes, which are acting as
reservoirs for viral replication, cross the BBB and enter the CNS resulting in inflammation
of brain tissue that could lead to HAD. The Tat protein has been shown to disrupt the
blood-brain barrier in vitro and in vivo, resulting in infiltration of monocytes into the CNS
through the disruption of tight junctions leading to HIV entry into the brain. This
disruption of the blood-brain barrier appears to result in infiltration of monocytes, which
can act as viral reservoirs as well as cause inflammation due to an accumulation of
perivascular macrophages. (Toborek et al., 2003; Andras et al., 2003; Cooper et al., 2012).
The extracellular matrix (ECM) is a structure found in animal tissue that provides
protection and support as well many other functions. The ECM includes two components,
the interstitial matrix and the basement membrane. The interstitial space is filled with
polysaccharides and proteins that reduce the stress put on the ECM by buffering
compression that occurs, while the epithelial cells rest on the basement membrane. The
ECM is involved in the regulation of numerous biological processes including adhesion
and migration of different cells. Specifically leukocytes are able to adhere and migrate into
specific tissues through adhesive functions using different receptors on the ECM. For
example, lymphocytes utilize interactions with a specific family of receptors known as
integrins. There have been different factors implicated in the modulation of integrin
receptors and the ECM (Springer, 1990; Hemler, 1990; Shimizu et al., 1991). The bloodbrain barrier provides a similar function to that of the ECM. Specifically, the blood-brain
barrier serves as a selective barrier between the peripheral circulation and the central
nervous system, and allows for the selective transport of cells in and out of the CNS.
14

However, while the BBB is more tightly regulated and controlled than the ECM, their
underlying function is similar. The BBB includes specialized brain microvascular
endothelial cells (BMECs), which are similar to the cells that rest on the basement
membrane. The BBB also consists of astrocytes, pericytes, microglia, and macrophages
(Fig. 2).
ECM proteins provide activation signals in the form of signal transduction through
integrins that result in functional cell changes such as adhesion and gene induction (Hynes,
1992; Juliano et al., 1993). While the signaling pathways involved in monocyte adhesion
are still not fully characterized, it is known that integrins can induce changes through
signaling transduction cascades. Monocytes play an important role as one of the first lines
of defense. They will adhere to and invade tissue when an inflammatory response is
detected. That is, monocytes transition from a non-adherent to an adherent state relatively
seamlessly. There are three main types of receptors that account for the transition from
adherent to non-adherent cells, members of the Ig family, integrins, and selectins (Rosales
et al., 1995). Of these, the most frequently found on leukocytes are members of the β
subfamily of integrins. It has been shown that without functional β1-integrins neutrophils
cannot respond properly to infection because they cannot adhere and cross the endothelium
at sites of infection (Anderson et al., 1987; Kuypers et al., 1989). Integrins are known to
act through signal transduction from the outside to the inside of the cell (Hynes, 1992;
Larson et al., 1990; Ruoslahti, 1991). Once monocytes adhere, or are differentiated into
macrophages using phorbol 12-myristate-13-acetate (PMA), gene induction will take place
(Eierman et al., 1989; Sporn et al., 1990) as a consequence of signal transduction cascades
15

and cross-linking of integrins (Yurochko et al., 1992). A link also has been shown to exist
between integrin-mediated gene induction and integrin-associated phosphorylation of
tyrosine residues involved in signal cascades (Lin et al., 1994a). However, further
investigation into integrin signaling pathways is required in order to fully understand the
role of integrins in signaling.
Cannabinoids are one of the oldest known drugs and have been shown to modulate
immune cells both in vivo and in vitro (Cabral et al., 2009). There are two main types of
cannabinoids, endogenous cannabinoids (endocannabinoids) such as anandamide and 2arachidonoyl glycerol (2-AG) that are produced naturally in vertebrates by many different
cells. Another major type of cannabinoids are exogenous cannabinoids (exocannabinoids),
such as the psychoactive phytocannabinoid Δ9-tetrahydrocannabinol (THC) found in the
plant Cannabis sativa, and synthetic cannabinoids that are manufactured in the laboratory.
One such synthetic cannabinoid is CP55940 among others.
There are two known cannabinoid receptors found in vertebrates. The cannabinoid
receptor type 1 (CB1R) that accounts for the psychoactive effects of the cannabis plant,
and the cannabinoid receptor type 2 (CB2R) that frequently is found in immune cells such
as B cells, T cells, monocytes, macrophages, and other immunocytes (Cabral & GriffinThomas, 2009). Both are 7-transmembrane G-protein coupled receptors. CB1R is
expressed primarily in the CNS while the CB2R is expressed mainly in cells of
hematopoietic origin. CB1R and CB2R exhibit a 44% amino acid homology throughout
the protein and 68% homology within the transmembrane domains (Oddi et al., 2011). In
addition, the G-protein-coupled receptor 55 (GPR55) may be a novel cannabinoid receptor.
16

Although GPR55 only contains 13.5% sequence homology to the CB1R and 14.4%
homology to the CB2R, it has been shown that a variety of cannabinoid compounds
activate signal transduction cascades associated with GPR55, including endogenous, plant,
and synthetic cannabinoids (Lauckner et al., 2008; Ryberg et al., 2007). Select
cannabinoids bind these receptors and activate signaling cascades involved in numerous
cellular processes.
It is known that exogenous cannabinoids such as THC can have effects on immune
system function (Cabral & Griffin-Thomas, 2009). Exogenous cannabinoids also have
been shown to alter immune cell chemotaxis to sites of infection or inflammation (Raborn
et al., 2008; Sacerdote et al., 2000). Most studies indicate that the receptor responsible for
this immune function modulation is the CB2R. One of the major cellular targets of action
for exogenous cannabinoids such as THC are macrophages and macrophage-like cells.
Cannabinoids can suppress normal cellular functions such as phagocytosis and spreading
as well as interfere with cell-contact-dependent lysis (Klein, 2005; Burnettecurley et al.,
1993). Current data also indicate that exogenous cannabinoids can have an inhibitory effect
on macrophage migration by modulating trafficking during infection and inflammation
(Cabral & Griffin-Thomas, 2009). However, definition of the full range of effects that
exogenous cannabinoids have on macrophage and macrophage-derived cells remains to be
defined.
As a consequence of being highly lipophilic, cannabinoids can cross the tightly
regulated BBB, suggesting that they may have therapeutic potential for treatment of
neuropathological disorders characterized by inflammation. While the CB1R is typically
17

known to be functionally linked to the psychoactive effects associated with marijuana, the
more “peripheral” CB2R is mainly involved in anti-inflammatory effects (Miller et al.,
2008). The CB2R has been identified in neurons, oligodendrocytes, and other glial cells in
tissue and the receptor can be induced during early inflammatory events (Cabral & GriffinThomas, 2009). The CB2R also has been identified in brain endothelium (Lu et al., 2008).
While the CB2R has been well studied, there still is limited information about the effects
of this receptor on brain endothelial cells.
One of the major cellular effects of exogenous cannabinoids such as THC (a partial
agonist at cannbinoid receptors) and CP55940 (a full agonist at cannabinoid receptors) is
that they modulate cell adhesion. The cannabinoid THC acts as a partial agonist of
cannabinoid receptors in that it only partially activates a given cannabinoid receptor. On
the other hand, CP55940 acts as a full cannabinoid receptor agonist as it displays full
efficacy at a given cannabinoid receptor. Not only are the expression levels of different
adhesion molecules modified upon activation of the CB2R, but it has been shown also that
intracellular adhesion can be decreased through CB2R signaling events that occur before
adhesion (Ramirez et al., 2012). One CB2R agonist, JWH133, has been shown to prevent
attachment and transendothelial migration of leukocytes in inflamed retinas (Xu et al.,
2007). Nevertheless, while the CB2R has been shown to decrease monocyte adhesion by
altering the surface expression of certain adhesion molecules and changing the integrity of
the tight junctions forming the BBB, the signal transduction pathway linked to these
activites remains unknown (Ramirez et al., 2012). Several signaling pathways have been
associated with the CB2R and its anti-inflammatory process, and while most of the
18

signaling cascades linked to its activation remain unknown there are specific cascades that
that have been studied. For example, it has been observed that CB2R effects have been
linked to mitogen-activated protein kinase (MAPK) signaling pathways that result in
alteration of the production of anti-inflammatory mediators (Basu et al., 2011). Another
pathway that has shown to be linked to CB2R signaling cascades is that involved in
alteration of the tight junction (TJ) complex, specifically the RhoA GTPase pathway
(Kurihara et al., 2006; Persidsky et al., 2006). Indeed, RhoA activity has been shown to
decrease in response to CB2R attenuation (Kurihara et al., 2006).
Previous studies in our laboratory have shown that treatment of cell lines
resembling primary human monocytes (HL-60 and the U937 cell lines) with the HIV
extracellular Tat protein results in increased cellular adhesion to the ECM proteins
collagen IV and laminin, as well as to a reconstituted complex ECM substrate. Previous
work in our laboratory has shown also that pre-treatment of these cell types with CB2R
partial and full agonists such as THC and CP55940, respectively, results in inhibition of
adhesion to extracellular matrix components enhanced by the Tat protein (Raborn et al.,
2013).
Scanning electron microscopy (SEM) has shown that primary human monocytes
undergo cytoskeletal rearrangement when treated with the Tat protein and allowed to
adhere to collagen IV-coated coverslips for 1 hour. The cells treated with Tat protein
assume a flattened-out appearance on coverslips and contain multiple projections
protruding from the cell consistent with enhanced binding to the ECM. These
morphological characteristics are distinctive from the rounded morphology that is
19

characteristic of the vehicle-treated monocytes consistent with minimal binding to the
ECM substrates. However, when these monocytes are pre-treated with THC or CP55940
for 2 hours followed by Tat treatment and examined for adherence to collagen IV-coated
coverslips for 1 hour, the binding to the ECM was reduced. The cells that are pre-treated
with THC or CP55940 appeared morphologically similar to the vehicle-treated cells (Fig.
3). The cannabinoid pre-treated cells maintained a more rounded and non-adherent
morphology while the cells treated only with Tat maintained their adherent state. These
results suggest a mode by which these cannabinoids act to prevent infiltration of monocytic
cells into the CNS, namely altering their ability to adhere to ECM substrates.
In addition, studies have been undertaken to gain insight regarding the specific
adhesion and migration molecules involved in cannabinoid-mediated reduction of adhesion
of peripheral monocytes to the ECM. Confocal immunofluorescence microscopy has
shown that THC and CP55940 alter the expression and distribution of β1-integrin and factin, two molecules that play a central role in cytoskeletal rearrangement and adhesion of
monocytes (Fig. 4).
The goal of this project is to characterize the signal cascades involved in HIV-1
Tat-mediated adhesion to the ECM and to determine the site of action at which THC and
CP55940 are operative in an inhibitory way in these pathways. Due to the modulatory
effects of cannabinoids using G-protein-coupled receptors, several specific molecules were
observed in the β1-integrin pathway. The effects of Tat in the presence or absence of THC
and CP55940 were observed in order to determine specific effects on signal transduction.
Included among the studies was an examination of effects on phosphorylation of focal
20

adhesion kinase, integrin receptor signaling (i.e. MAPK), and PI3 kinase (Fig. 5). The
hypothesis tested was that a novel convergent point existed early on in a signal
transduction pathway between Tat-enhanced adhesion to the ECM and the cannabinoidinduced ablation of this adhesion. Identification of a convergent point along the signal
transduction pathway could yield novel insight into the signal transduction pathways
involved in Tat-mediated adherence and could contribute toward development of novel
treatment methods for HIV-associated neurocognitive disorders in which a cannabinoid
receptor would serve as a molecular target.
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Figure 1 – An overview of the different domains present in the HIV protein Tat. This is a
representation of the five Tat domains: The N-terminal domain I (aa 1-20), cysteine-rich domain II (aa
21-40), hydrophobic core domain III (aa 41-48), RNA-binding domain IV (aa 49-72), a glutamate rich
region (aa 49-72) that is necessary for transactivation and final the C-terminal domain V of variable
size (73-86 or 73-101) (Kuciak et al., 2008).
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Blood

Brain

Figure 2 – The physiology of the blood brain barrier. It is made up of brain microvascular endothelial
cells (BMECs) that are surrounded by pericytes and astrocytes. Its function is to provide a separation
between the peripheral circulation and the central nervous system (CNS). It is very highly regulated
and monocytes that gain entry into the CNS develop into macrophages. Tight junctions are established
between the BMECs providing protection of the blood-brain barrier (Strazza et al., 2011).
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Figure 3: Light and Scanning electron micrographs of U937 macrophage-like cells seeded on collagen
IV demonstrate morphological alterations in cell adherence following treatment with Tat or with Tat
in combination with cannabinoids. a-d- Light micrographs of U937 cells allowed to adhere (1h) to
collagen IV-coated 96 well plates following pretreatment (2h) with: a. Vehicle (serum-free RPMI
containing 0.01% ethanol + PBS), b. Tat (50 nM) plus 0.01% ethanol c. Tat (50 nM) plus THC (1 µM)
and d. Tat (50 nM) plus CP55940 (1 µM). Scale bars depict 200 µM. e-k- Scanning electron
micrographs of U937 cells seeded on collagen IV-coated coverslips illustrating morphology following
treatment with Tat or with Tat in combinations with cannabinoids. e. Vehicle (serum-free RPMI
containing 0.01% ethanol + PBS), f-h. Tat (50 nM) plus 0.01% ethanol, i-j. Tat (50 nM) plus THC (1
µM), and k. Tat (50 nM) plus CP55940 (1 µM) (Courtesy of Erinn Raborn).
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Figure 4: Treatment with THC of CP55940 alters distribution of β1- integrin and polymerized actin.
U937 cells were pretreated (2h) with cannabinoid (THC or CP55940)(1 µM) plus Tat (50 nM), then
seeded on collagen IV-coated chamber slides and allowed to adhere (1 h). Fixed cells were stained with
anti-human-β1- integrin-FITC antibody followed by Phalloidin-AlexaFluor594 to visualize f-actin. Cell
nuclei were counterstained with DAPI. The left column depicts the merged images of actin and β1integrin while the right column depicts images of β1- integrin. Insets depict magnified singular cells.
Images – 100x (Courtesy of Erinn Raborn).
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Figure 5: A schematic overview of Rho-GTPase signaling as it pertains to cell migration. Rho, Rac and
Cdc42 are the best-characterized members of this family of monomeric GTPases. They exert their
action when extracellular stimuli transduce signals to upstream Rho-GTPase activators known as
guanine nucleotide exchange factors (GEFs). Activated Rho, Rac or Cdc42 bind to downstream
effector kinases, which then phosphorylate a plethora of substrates leading to dynamic reorganization
of the actin cytoskeleton essential to the efficacy of directed cell migration (Rutka, 2008).
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Cannabinoid
THC
CP55940

Table 1 – Cannabinoid Receptor Ligands
Classification
Dissociation Constant (Ki)
CB1R ki
CB2R ki
Low efficacy
40.7nM
36.4nM
CB1R/CB2R agonist
High efficacy
1.37nM
1.37nM
CB1R/CB2R agonist

Abbreviations – THC, (δ-tetrahydrocannabinol); CP55940, ((-)-cis-3-[2-Hydroxy-4-(1,1dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol)

Adapted from (Howlett et al., 2002)
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Materials and Methods

Cell Culture
The human promyelocytic leukemia cell line (HL-60) was obtained from ATCC,
Manassas, VA. Cells were maintained in complete RPMI1640 medium (Cellgro, Herndon,
VA) containing 10% fetal bovine serum and supplemented with 1% L-glutamine, 1%
nonessential amino acids, 1% minimal essential medium vitamins, 0.01 M HEPES, and
penicillin (100U/mL)/streptomycin (100 ug/ml)/fungizone (0.25ug/ml)(Cellgro). Cell
cultures were maintained at 37oC with 5% CO2 in ventilated T-175 flasks (Greiner Bio
One, Monroe, NC). For cell lines that were differentiated into macrophages complete
RPMI was supplemented with either 1µM all-trans-retinoic acid (Fischer Scientific,
Waltham, MA) or 16 nM phorbol 12-myristate-13-acetate (Fisher Scientific #BP685-1).
Tat
Recombinant human HIV-1 Tat1-86 protein (E. coli) was obtained from
Immunodiagnostics, Inc. (Woburn, MA). Tat was dissolved in sterile sodium citrate (10
uM) and frozen aliquots were stored at -80oC until converted to a working solution
according to the manufacturer’s recommendation. For in vitro administration, special lowretention microfuge tubes (Thermo Fisher Scientific, Waltham, MA) and low-binding
pipette tips (VWR, West Chester, PA) were used to minimize Tat loss.
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Cannabinoids
The partial CB1 receptor/ CB2 receptor (CB1R/CB2R) agonist Delta-9-tetrahydrocannbinol
and the full CB1R/CB2R agonist CP55940 were obtained from the Department of
Pharmacology and Toxicology (Virginia Commonwealth University, Richmond, VA).
Stock solutions of cannabinoids (10-2 M) were prepared in 100% ethanol and stored at -20
o

C. Experimental concentrations were obtained by dilution of cannabinoid stock solutions

in assay medium (RPMI 1640 medium) to yield a final ethanol concentration of 0.01%.
The vehicle control for cannabinoids consisted of 0.01% ethanol in a medium for
cannabinoid treatment, equal volume of sterile sodium citrate for Tat treatments, or 0.01%
ethanol plus sodium citrate for cannabinoid/Tat treatments.
Western ImmunoBlot Analysis for CB2R, GPR55, and B1-integrin probes
For Western immunoblot analysis, cells were centrifuged (1000 x g, 10 min, 4oC) and
pellets were washed with room temperature PBS (2x) then resuspended in serum-free
RPMI 1640. The cells were lysed using dH2O containing 1% protease inhibitor cocktail
(Sigma-Aldrich #P8340-1ML) and subjected to freeze-thawing 4 times using liquid
nitrogen and a room temperature water bath. The protein concentration of lysates was
determined using the Bradford method (Bradford, 1976), and 30 µg of protein were
subjected to separation in a 10% SDS-polyacrylamide gel (SDS-PAGE). After
electrotransfer to a nitrocellulose membrane using a Fischer Scientific FB200 apparatus the
membranes were blocked in 5% non-fat milk in Tris-buffered saline (TBS), containing
0.2% -Tween 20 (TBST) for 1h at room temperature. The membranes then were washed (5
min) in TBST and incubated overnight at 4oC with primary antibody in 5% milk in TBST.
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Primary antibodies consisted of anti-CB2R diluted 1:100 in 5% milk/TBST (Nowell et al.,
1998), anti-GPR55 5µg/mL in 5% milk/TBST (Caymen Chemical #10224), and anti-β1integrin diluted 1:1000 in 5% milk/TBST (Sigma-Aldrich #GW22754). Membranes were
washed with TBST (3 times, 5 min each) and incubated with the appropriate secondary
antibodies, anti-CB2R utilized goat anti-rabbit at 1:5,000 dilution in 5% milk/TBST, antiGPR55 utilized goat anti-rabbit at 1:5,000 dilution in 5% milk/TBST, anti-β1-integrin
utilized rabbit anti-chicken at 1:10,000 dilution in 5% milk/TBST. After 6 washes with
TBST (5 min each), the membranes were subjected to enhanced chemiluminescence
according to the manufacturer’s instructions (GE Healthcare, Cleveland, OH) .
Western ImmunoBlot Analysis for Focal Adhesion Kinase
For Western immunoblot analysis, cells were centrifuged (1000 x g, 10 min, 4oC) and
pellets were washed with room temperature PBS (2x) then resuspended in serum-free
RPMI 1640. The cells were lysed using the modified Radio Immunoprecipitation Assay
(RIPA) buffer mentioned previously plus a 1% protease inhibitor cocktail (Sigma-Aldrich
#P8340-1ML). The protein concentration of lysates was determined using the Bradford
method (Bradford, 1976) and 30 µg of protein were subjected to separation in a 10% SDSPAGE. After electrotransfer to a nitrocellulose membrane using a Fischer Scientific FB200
apparatus the membranes were blocked in 5% non-fat milk in Tris-buffered saline (TBS),
containing 0.2% -Tween 20 (TBST) for 1h at room temperature. The membranes then were
washed (5 min) in TBST and incubated overnight at 4oC with primary antibody in 5% BSA
in TBST at a dilution of 1:1,000. Primary antibodies consisted of rabbit anti-mouse focal
adhesion kinase or phosphorylated focal adhesion kinase proteins (Cell Signaling
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Technology #3283 and #3285, respectively). Membranes were washed with TBST (3
times, 5 min each) and incubated with secondary horseradish peroxidase-conjugated goat
anti-rabbit antibody at a dilution of 1:2,000 in 5% milk/TBST. After 6 washes with TBST
(5 min each), the membranes were subjected to enhanced chemiluminescence according to
the manufacturer’s instructions (GE Healthcare, Cleveland, OH).
Scanning Electron Microscopy
For attachment assays wells were coated with ECM gel (Sigma-Aldrich, St. Louis, MO)
from Engelbreth-Holm-Swarm murine on the day of use. Upon polymerization, ECM gel
forms a reconstituted basement membrane containing laminin, type IV collagen, heparan
sulfate proteoglycan, enactin, and other minor components. ECM gel stock (stock solutions
8-12 mg/mL) was washed 2x with PBS, then diluted 1:3 in RPMI without serum and added
to wells for 10 min at room temperature. To examine for adhesion to the ECM, HL 60 cells
(105) were pretreated with vehicle (serum-free RPMI containing 0.01% ethanol drug and
sodium citrate) or Tat (50nM) alone or in combination with cannabinoid (THC, CP55940;
1µM) then incubated (2 h, 37oC) on tissue culture inserts coated with to an ECM gel
described above. The inserts then were immersed for 1 hour in 2.5% glutaraldehyde in
0.1M cacodylate buffer, pH 7.2, washed four times with PBS, and treated (40 min in the
dark) with 2% osmium tetroxide buffered in 0.1M cacodylate buffer, pH 7.2. The inserts
were washed with PBS, dehydrated in a graded series of ethanol dilutions, subjected to
critical-point drying with CO2 as the transitional fluid, mounted on stubs and coated with
gold (30nm) (Rocha-Azevedo et al., 2007). Samples were examined in a Zeiss EVO
50XVP scanning electron microscope operating at an accelerating voltage of 15 kV.
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Sample Preparation for detection of p-Tyr Proteins Using Microarrays
To prepare HL-60 lysates and cell-conditioned media, 1x107 HL-60 cells were seeded in a
6-well plate with complete RPMI. After two days, complete medium was replaced with
serum free RPMI. Supernatants and cells were collected separately 48h later. To prepare
cell lysate, cells were lysed with a modified RIPA buffer mentioned previously plus a 1%
protease inhibitor cocktail (Sigma-Aldrich #P8340-1ML) and protein concentrations were
determined using the Bradford method (Bradford, 1976).
Detection of p-Tyr Proteins Using Microarrays
Microarrays were performed according to RayBio Human RTK Phosphorylation Antibody
Array (RayBiotech, Inc., Norcross, GA, USA). First, the array was blocked using a
blocking buffer provided by RayBio. Next, a lysate concentration of 600 µg were loaded
onto each plate for the different treatment conditions. The plates were then incubated
overnight at 4oC. Unbound materials were washed away using TBST and biotinylated antiphosphotyrosine antibody was added. The plates were then incubated for 2 h at room
temperature. After another wash, streptavidin-conjugated HRP antibodies were added and
the plates were incubated for another 2 h at room temperature. After extensive washing,
detection was performed using chemiluminesence detecting with film. Densitometry was
then performed by scanning the arrays and using QuantiOne software from Bio-Rad
(Hercules, CA) and standards were generated using the controls provided on the plate. The
relative densities of the samples were determined by comparison to the standards provided.
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Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Real-time Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for extracellular
matrix and adhesion molecules (SABiosciences #PAHS-128Z) was used for detection of
adhesion and extracellular matrix molecules to assess the levels of mRNA. HL-60 cells
were treated with vehicle (serum-free RPMI + Sodium citrate + 0.01% ethanol), 50 nM
Tat, 50nM Tat + 1µM CP55940, or 50nM Tat + 1µM THC suspended in serum-free RPMI
and incubated at 37ºC in 5% CO2 for 8 h. Total RNA was prepared using TRIzol reagent
(Invitrogen) according to the manufacturer’s instruction. The RNA was extracted using
chloroform:isopropanol and resuspended in 30 uL PCR grade water. The isolated RNA
was treated with RNase-free DNase I Amplification grade (QUIAGEN) to remove residual
genomic DNA. Reverse transcription (RT) was performed in a Bio-Rad iCycler (BioRad,
Richmond, VA) using the RT2 First Strand Synthesis Kit (QIAGEN) used to generate
complimentary DNA (cDNA). The cDNA template was combined with an instrument
specific and ready-to-use RT2 SYBR Green qPCR Master Mix. Equal aliquots of this
mixture (25 uL) were added to each well of the same PCR Array plate containing the
predispensed gene-specific primer sets (QIAGEN). The plates containing the PCR mix
were placed in the SmartCycler (Cepheid, Sunnyvale, CA) and PCR was performed using
the following program: 95°C, 15 min; 40 cycles of (95°C, 30 sec; 55°C, 30 sec; and 72°C,
30 sec). The resulting PCR products were calculated using the threshold cycle (Ct) values
for all the genes on the PCR Array. Fold changes in the gene expression in pairs were
calculated using the ΔΔCt method. Built-in RNA quality controls were also utilized to
provide the relative levels of genomic DNA contamination and inhibitors of either the
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reverse transcription or the PCR itself. By examining the Ct value consistency for the
housekeeping genes a normalization method was determined.
RhoA Activation Sample Preparation and Lysate Collection
HL-60 Cells were plated into 6-well FALCOLN multi-well plates. Cells were grown in
cell culture media under the conditions described above for 4 days and supplemented with
1µM all-trans-retinoic acid (ATRA) as described under the cell culture conditions to
differentiate them into macrophage-like cells. After 4 days cells were switched to serumfree RPMI onto plates coated with human fibrinogen. Plates coated with human fibrinogen
were prepared by coating plates with 100ug/mL of human fibrinogen (Invitrogen)
suspended in PBS and incubated at 4ºC overnight. Prior to use the unpolymerized human
fibrinogen was removed and washed away with PBS. After switching the cells to
fibrinogen coated plates and serum-free RPMI, they were incubated overnight. HL-60 cells
were then treated with 50nM Tat at different time points in the presence and absence of
cannabinoids (THC, CP55940 at 1µM) at specific time points between 30 sec and up to 30
min. Following treatment under given experimental conditions the treatment was removed
and the cells were washed 2x with ice-cold PBS. Cells were then lysed using a lysis buffer
provided by Cytoskeleton (#CLB01-S) supplemented with 1% Protease Inhibitor Cocktail
(Sigma-Aldrich #P8340-1ML) and harvested by scraping the adherent cells from the plate.
Lysates were snap-frozen in liquid nitrogen and stored at -80ºC for further analysis. Protein
concentration was determined using the Bradford Assay (Bradford, 1976).
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RhoA Activation Pulldown Assay
Pulldown assays were performed on activated RhoA using a Biochem Kit (Cytoskeleton
#BK036-S, Denver, CO). The pulldown assay was performed according to the protocol
provided by Cytoskeleton.
Western ImmunoBlot Analysis for RhoA Activation
For Western immunoblot analysis, 25 µg of protein were subjected to separation on either
a 10% or 12% SDS-PAGE. After electrotransfer to a nitrocellulose membrane using a
Fischer Scientific FB200 apparatus the membranes were blocked in 5% non-fat milk in
Tris-buffered saline (TBS), containing 0.2% -Tween 20 (TBST) for 1h at room
temperature. The membranes then were washed (5 min) in TBST and incubated overnight
at 4oC with anti-RhoA mouse monoclonal antiboides (Cytoskeleton #ARH03) in TBST at
a dilution of 1:500. Membranes were washed with TBST (1 time, 5 min) and incubated
with secondary horseradish peroxidase-conjugated goat anti-mouse antibody (Organon
Teknika Corp., Westchester, PA #55550). After 6 washes with TBST (10 min each), the
membranes were subjected to enhanced chemiluminescence according to the
manufacturer’s instructions (GE Healthcare).
Statistics
One Way Analysis of Variance (ANOVA) was performed to assess for differences
between treatment groups. Bonferroni’s t-test was used to compare differences in Tattreated cells versus cells treated with cannabinoid in the presence of Tat, in addition to
differences between treatment groups.
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Results

Human Promyelocytic Leukemia cell (HL-60) Expression of the Cannabinoid Receptor
CB2R, GPR55, and B1-integrin Receptor
The cannabinoids THC and CP55940 bind to cannabinoids receptors CB1, CB2 and
GPR55 (Herkenham et al., 1990). Therefore in order to show that the cell line used in
present study expresses these receptors, SYBR Green RT-PCR for the CB1R, CB2R, and
GPR55 mRNA was employed. A 207 bp amplicon that is consistent with the size predicted
for CB2R was detected in the total mRNA extracted from the HL-60 cells (Fig. 6).
Whole cell lysates of HL-60 cells were subjected to western immunoblotting using
a mouse CB2R and GPR55 domain-specific antibody to confirm the presence of CB2R and
GPR55 (Fig. 7). The presence of the β1-integrin receptor was also probed for since it plays
a critical role in cytoskeletal rearrangement and adhesion (Lafrenie et al., 1996). HL-60
whole cell lysates were also used to probe for the β1-integrin receptor using an AntiIntegrin β1 antibody produced in chicken (Fig. 8). Based on these data HL-60 cells were
shown to express these proteins at both the mRNA and protein levels.
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Figure 6 – CB2R mRNA expressed in human promyelocytic leukemia cells (HL-60). RT-PCR revealed
amplification of a 207 bp amplicon consistent with the presence of CB2R mRNA. (-) – negative dH2O
control
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Figure 7 – Human Promyelocytic Leukemia cells (HL-60) Express the CB2R and GPR55 at the protein
level. Whole cell lysates from HL-60 cells were separated by SDS-PAGE followed by Western
immunoblot analysis with antibodies to the CB2R, GPR55, or Actin. After stripping of the membrane
actin detection was performed on the corresponding membrane that was used to detect CB2R or
GPR55.
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Figure 8 – Human Promyelocytic Leukemia cells (HL-60) Express β1-integrin at the protein level.
Whole cell lysates from HL-60 cells were separated by SDS-PAGE followed by Western immunoblot
analysis with antibodies to β1-integrin and Actin. After stripping of the membrane actin detection was
performed on the corresponding membrane that was used to detect β-integrin.
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Tat induces Cytoskeletal Rearrangement in HL-60 Promyelocytic Cells.
When human promyelocytic leukemia cells were treated with 50nM Tat over a 10
min time point a time-dependent reorganization of f-actin was observed. Treatment using
50nM Tat protein demonstrated induction of actin polymerization over a 20 min time
course (Fig. 9a and Fig. 9b).

Tat

Vehicle

Similarly, when HL-60 cells were observed attaching and penetrating an ECM gel
(Sigma) using scanning electron microscopy following treatment with 50nM Tat and a
vehicle treatment, further evidence of cytoskeletal rearrangement was observed (Fig. 10).
Fingerlike projections were noted for in the Tat-treated cells showing adherence whereas
minimal projections were seen for vehicle-treated cells (not shown here).
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Figure 9a - HL-60 cells were seeded on glass coverslips and differentiated with complete RPMI containing 10% FBS and
phorbol 12-myristate-13-acetate (PMA) (16nM, 4days). HL-60 cells were treated with Vehicle (RPMI+ sodium citrate)(0
min) or 50 nM Tat (5-20 min), then fixed with 4% paraformaldehyde. Actin polymerization was visualized by staining the
coverslips with AlexaFluor-Phalloidin (1:500)(2h). ProLong Gold Antifade Reagent containing the nuclear counterstain
DAPI was used to mount the coverslips and stabilize the fluorescent signal. Scale bars- 100mm
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Figure 9b – 20x Images, HL-60 cells were seeded on glass coverslips and differentiated with complete RPMI containing 10%
FBS and phorbol 12-myristate-13-acetate (PMA) (16nM, 4days). HL-60 cells were treated with Vehicle (RPMI+ sodium
citrate)(0 min) or 50 nM Tat (5-20 min), then fixed with 4% paraformaldehyde. Actin polymerization was visualized by
staining the coverslips with AlexaFluor-Phalloidin (1:500)(2h). ProLong Gold Antifade Reagent containing the nuclear
counterstain DAPI was used to mount the coverslips and stabilize the fluorescent signal. Scale bars- 300mm
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Figure 10: Scanning electron micrographs of HL-60 macrophage-like cells seeded on ECM gel (Sigma
Aldrich) demonstrate morphological alterations in cell adherence following treatment with 50nM Tat
(10 µM) (Courtesy of Dr. F.M. Cabral). Control images not shown.
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Receptor Tyrosine Kinase (RTK) Multiplex Assay of Human Promyelocytic Leukemia Cells
shows Tat up-regulates specific RTK-Molecules while the Cannabinoids THC and
CP55940 down-regulate the same Molecules.
In order to identify a possible signal transduction cascade involved in both Tat
induced inflammation and cannabinoid inhibited inflammation, phosphorylation levels of
specific tyrosine kinase (TK) molecules were assessed. TKs have been implicated in many
cellular processes. Often these occur through the transfer of a phosphate group to a
substrate. This phosphorylation can induce changes at the cytoskeletal level including
attachment and invasion of certain cells. Concurrently, such phosphorylation can activate
or inhibit different cellular processes. In view of these effects the phosphorylation of
different TKs was evaluated. Using a tyrosine kinase array, an increase in phosphorylation
of several TKs was seen at a 10 min time point for cells treated with Tat as compared to
cells treated only with vehicle. The phosphorylation levels of these TKs then decrease
towards baseline at the 20 min time point (Fig. 12). Maximal phosphorylation was
observed following treatment using 50nM Tat at the 10 min time point.
In order to identify the effects of cannabinoids on the phosphorylation levels of the
specific tyrosine kinase molecules, HL-60 cells were treated with 50nM Tat concurrently
with CP55940 or THC. Cells were also treated only with CP55940 in order to confirm that
a cannabinoid by itself did not alter phosphorylation of the indicated protein species.
Phosphorylation was observed in cells treated with vehicle, 50nM Tat, 50nM Tat treatment
+ cannabinoid. Several of the receptor tyrosine kinases demonstrated an increase in
phosphorylation upon exposure to Tat. This phosphorylation was diminished upon
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cannabinoid treatment in concert with the Tat exposure (Fig. 14a. & b.). Specifically,
phosphorylation of TKs Fgr, Pyk2, and Syk was modulated by the introduction of
cannabinoids. Each of these 3 molecules is involved in the Rac-Rho β-integrin cellular
adhesion pathway.
The TK membranes contained intrinsic positive controls found in row 1, A through
F. The densitometry of the 3 different positive controls for each membrane was determined
in duplicate and the results were standardized to the differences in the positive controls.
Similarly the density of each TK was also done in duplicate, averaged and standardized
using the 3 separate positive controls. This approach allowed for the determination of
relative densities of the different TKs while still adjusting for variance between the plates.
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Figure 11 –RTK phosphorylation multiplex assay for adhesion and invasion. HL-60 lysates were
prepared and used to probe the array, cells were treated with Vehicle (RPMI + sodium citrate), 50nM
Tat for 10 min., and 50nM Tat for 20 min. The grid depicts the topography of the blots for the
different receptor tyrosine kinases.
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Figure 12 –Quantitative data from Fig. 11. The graph depicts greater than 2-fold increase of
phosphorylation levels compared to vehicle treatment (RPMI+ sodium citrate + 0.01% Ethanol) of
50nM Tat treatments at 10 min (Red) and 20 min (Purple). Densitometry was then performed on the
membranes and results were graphed according to optical density. Receptor Tyrosine Kinases
phosphorylation showing less than 2-fold change were not included in the graph.
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Figure 13 - Receptor Tyrosine Kinase (RTK) phosphorylation multiplex assay for adhesion and
invasion. HL-60 cells were lysed and prepared using methods described by RayBio® protocol. HL-60
cells were treated with Vehicle (RPMI + sodium citrate); 50nM Tat for 10 min.; 1µM CP55940 for 10
min., 50nM Tat + 1µM CP55940 for 10 min; 50nM Tat + 1µM THC for 10 min. The grid depicts the
topography of the blots for the different receptor tyrosine kinases.
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Figure 14a – Graph showing treatment of HL-60 cells with 50 nM Tat protein for 10 min. shown in
blue; and 50nM Tat protein + CP55940 for 10 min. shown in red compared to vehicle (serum-free
RPMI + sodium citrate + 0.01% ethanol) for 10 min. and plotted as fold change. Densitometry was
performed on the membranes and the results were graphed according to optical density. Receptor
Tyrosine Kinases phosphorylation showing less than 2-fold change were not included.
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Figure 14b – Graph showing treatment of HL-60 cells with 50 nM Tat protein for 10 min. shown in
blue; and 50nM Tat protein + CP55940 for 10 min. shown in red compared to vehicle (serum-free
RPMI + sodium citrate + 0.01% ethanol) for 10 min. and plotted as fold change. Densitometry was
performed on the membranes and the results were graphed according to optical density. Receptor
Tyrosine Kinases phosphorylation showing less than 2-fold change were not included.
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Tat Protein does not alter Focal Adhesion Kinase (FAK) Expression nor FAK
Phosphorylation in HL-60 Cells that are differentiated into Macrophages
Phosphorylation at Tyr-397 was assessed because this residue was implicated in
autophosphorylation that mediates cellular adhesion (Calalb et al., 1995) (Fig. 5). The
tyrosine kinase FAK was observed using western blot analysis probing with specific
polyclonal antibodies detecting phosphorylation at Tyr-397 for the FAK molecule. HL-60
cells were differentiated into macrophage-like cells over 4 days using phorbol 12myristate-13-acetate (PMA). Detection of phosphorylation at tyrosine-397 on the molecule
FAK was performed using western blot analysis after treatment of cells with 50nM Tat
protein at time points ranging between zero and twenty minutes. A time-dependent
increase was observed in the phosphorylation of tyrosine-397 on focal adhesion kinase
between five and ten minutes after treatment of 50 nM Tat protein (Fig. 15a). However,
this increase in phosphorylation was also observed in the vehicle treated cells (Fig. 15b).
This increase is likely due to the fact that sodium citrate can also act as an activating agent.
Expression levels of unphosphorylated FAK were also observed at different time
points to assess the expression levels of the FAK protein during treatment with Tat. Again,
HL-60 cells were differentiated into macrophage-like cells using PMA over a 4-day period.
Detection of the FAK protein was performed using western immunoblotting after
treatments of either vehicle or 50nM Tat at given time points. Increased levels of FAK
were seen for Tat treatments at 10 and 20 min as compared to vehicle (0 min. stimulation).
A protein band was observed that corresponded to an approximate relative molecular
weight of 50 kD which is not the predicted size of the full-length FAK protein (Fig. 15).
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The predicted molecular weight of FAK was 125 kDa, which is different from the
observed 50 kDa band. Since no significant alteration was seen in the phosphorylation of
FAK the next molecule in the β-integrin signaling transduction pathway, RhoA, was
investigated.
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Figure 15 – Western immunoblot of HL-60 cells differentiated over 4 days using phorbol myristate
acetate. Cells were treated with (a). 50nM Tat for 2.5, 5, 10, and 20 min or (b). Vehicle (sodium citrate
+ 0.01% ethanol). Lysates were prepared using a modified RIPA buffer and western immunoblotting
was performed according to the Cell Signaling Technology® protocol. FAK phosphorylated antibodies
were used to detect phosphorylation levels of FAK (Cell Signaling Technologies #3283). α-Actin was
used as a control for proper loading of each lane with equal concentrations of protein.
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Figure 16 – Western immunoblot of HL-60 cells differentiated over 4 days using phorbol 12-myristate13-acetate. Cells were treated with either Vehicle (sodium citrate + 0.01% ethanol) or 50nM Tat for
2.5, 10, and 20 min. Lysates were prepared using a modified RIPA buffer and western immunoblotting
was performed according to the Cell Signaling Technology® protocol. FAK antibodies were used to
detect phosphorylation levels of FAK (Cell Signaling Technologies #3285). α-Actin was used as a
control for proper loading of each lane with equal concentrations of protein.
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Transcripts for Proteins Linked to Extracellular Matrix and Adhesion or Cell Motility
Molecules are not affected by Tat in the Presence and Absence of Cannabinoid
In order to determine if mRNA expression of adhesion molecules is altered in the
context of Tat in the presence or absence of cannabinoids, an RT-PCR array kit from
SABiosciences observing cell motility was employed. HL-60 cells were plated and treated
with vehicle (sodium citrate + 0.01% ethanol), 50nM Tat, 50nM Tat + 1µM THC, 50nM
Tat + 1µM CP55940 and placed in the incubator for 8 h. RNA extraction was then
performed on the cells, the isolated RNA was added to a cDNA template in equal aliquots
and RT-PCR was employed to quantitate the mRNA expression of the different genes.
Vehicle treatments were first compared to the 50nM Tat treatments and a scatter plot was
generated comparing Tat treatment to vehicle (Fig. 17). A heat map was also generated
comparing Tat treatments to the vehicle treatments (Fig. 18). No statistically significant
differences in mRNA gene expression were seen in the 84 genes probed on the RT-PCR
Array Plate when comparing 50nM Tat treatment to vehicle treatment.
The 50nM Tat treatment alone was then compared to 50nM Tat treatment in the
presence of cannabinoids. A scatter plot was generated comparing Tat treatments to Tat +
THC treatment (Fig. 19). Also a heat map was generated comparing the two (Fig. 20). In
addition, a scatter plot (Fig. 21) and heat map (Fig. 22) were generated comparing Tat
treatments to Tat + CP55940. No statistically significant differences were seen when
comparing the RT-PCR of Tat treatments to Tat treatments with cannabinoids during an 8h
time point. Table 2 demonstrates the position of the different mRNAs on the plate as well
as a brief description of the cognate genes and alternative description designations.
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Figure 17 – Scatter plot of the 84 key genes involved in cell movement and attachment comparing
vehicle vs. Tat treatments. The graph depicts Vehicle treatment (sodium citrate + 0.01% ethanol) on
the X-axis (Control Group) plotted vs. 50nM Tat treatment along the Y-axis (Group 1). Expression has
been normalized using housekeeping genes present on the array and the scatter plot allows for quick
visualization of large gene expression changes. The central line indicates gene expression changes and
the boundaries indicate 2-fold increases or decreases in expression.
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Figure 18 - Heat plot of 50nM Tat vs. Vehicle (Sodium citrate + 0.01% ethanol). This plot provides a
graphical representation of fold regulation expression data between two groups overlaid onto the PCR
Array plate layout. The brighter green represents a decrease in mRNA levels of the particular gene
whereas the brighter red indicates an up-regulation of the mRNA levels of the particular gene as
compared to Vehicle (sodium citrate + 0.01% ethanol). Grey represents no data present for the gene.
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Figure 19 – Scatter plot of the 84 key genes involved in cell movement and attachment comparing Tat
vs. Tat + THC. The graph depicts 50nM Tat + 1 µM THC treatment along the X-axis (Group 2) vs.
50nM Tat treatment on the Y-axis (Group 1) plotted. Expression has been normalized using
housekeeping genes present on the array and the scatter plot allows for quick visualization of large
gene expression changes. The central line indicates gene expression changes and the boundaries
indicate 2-fold increases or decreases in expression.
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Figure 20 – Heat plot of 50nM Tat + THC vs. 50nM Tat. This plot provides a graphical representation
of fold regulation expression data between two groups overlaid onto the PCR Array plate layout. The
brighter green represents a decrease in mRNA levels of the particular gene whereas the brighter red
indicates an up-regulation of the mRNA levels of the particular gene as compared to 50nM Tat
treatments. Grey represents no data present for the gene.
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Figure 21 – Scatter plot of the 84 key genes involved in cell movement and attachment comparing Tat
vs. Tat + CP55940. The graph depicts 50nM Tat + 1 µM CP55940 treatment along the X-axis (Group
3) vs. 50nM Tat treatment on the Y-axis (Group 1) plotted. The expression has been normalized using
housekeeping genes present on the array and the scatter plot allows for quick visualization of large
gene expression changes. The central line indicates gene expression changes and the boundaries
indicate 2-fold increases or decreases in expression.
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Figure 22 - Heat plot of 50nM Tat + CP55940 vs. 50nM Tat. This plot provides a graphical
representation of fold regulation expression data between two groups overlaid onto the PCR Array
plate layout. The brighter green represents a decrease in mRNA levels of the particular gene whereas
the brighter red indicates an up-regulation of the mRNA levels of the particular gene as compared to
50nM Tat. Grey represents no data present for the gene.
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Position

Symbol

Description

Gene Name

A01

ACTN1

Actinin, alpha 1

FLJ40884, FLJ54432

A02

ACTN3

Actinin, alpha 3

MGC117002, MGC117005

A03

ACTN4

Actinin, alpha 4

ACTININ-4, DKFZp686K23158, FSGS,
FSGS1

A04

ACTR2

ARP2 actin-related protein 2 homolog
(yeast)

ARP2

A05

ACTR3

ARP3 actin-related protein 3 homolog
(yeast)

ARP3

A06

AKT1

A07

ARF6

ADP-ribosylation factor 6

DKFZp564M0264

A08

ARHGDIA

Rho GDP dissociation inhibitor (GDI)
alpha

GDIA1, MGC117248, RHOGDI, RHOGDI-1

A09

ARHGEF7

Rho guanine nucleotide exchange
factor (GEF) 7

BETA-PIX, COOL-1, COOL1,
DKFZp686C12170, DKFZp761K1021,
KIAA0142, KIAA0412, Nbla10314, P50,
P50BP, P85, P85COOL1, P85SPR, PAK3,
PIXB

A10

BAIAP2

BAI1-associated protein 2

BAP2, FLAF3, IRSP53

A11

BCAR1

Breast cancer anti-estrogen resistance
1

CAS, CAS1, CASS1, CRKAS, FLJ12176,
FLJ45059, P130Cas

A12

CAPN1

Calpain 1, (mu/I) large subunit

CANP, CANP1, CANPL1, muCANP, muCL

B01

CAPN2

Calpain 2, (m/II) large subunit

CANP2, CANPL2, CANPml, FLJ39928,
mCANP

B02

CAV1

Caveolin 1, caveolae protein, 22kDa

BSCL3, CGL3, MSTP085, VIP21

B03

CDC42

Cell division cycle 42 (GTP binding
protein, 25kDa)

CDC42Hs, G25K

B04

CFL1

Cofilin 1 (non-muscle)

CFL

B05

CRK

V-crk sarcoma virus CT10 oncogene
homolog (avian)

CRKII

B06

CSF1

Colony stimulating factor 1
(macrophage)

MCSF, MGC31930

V-akt murine thymoma viral oncogene AKT, MGC99656, PKB, PKB-ALPHA, PRKBA,
homolog 1
RAC, RAC-ALPHA

B07

CTTN

Cortactin

EMS1, FLJ34459

B08

DIAPH1

Diaphanous homolog 1 (Drosophila)

DFNA1, DIA1, DRF1, FLJ25265, LFHL1,
hDIA1

B09

DPP4

Dipeptidyl-peptidase 4

ADABP, ADCP2, CD26, DPPIV, TP103

B10

EGF

Epidermal growth factor

HOMG4, URG

B11

EGFR

Epidermal growth factor receptor

ERBB, ERBB1, HER1, PIG61, mENA

B12

ENAH

Enabled homolog (Drosophila)

ENA, MENA, NDPP1

C01

EZR

Ezrin

CVIL, CVL, DKFZp762H157, FLJ26216,
MGC1584, VIL2

C02

FAP

Fibroblast activation protein, alpha

DKFZp686G13158, DPPIV, FAPA

C03

FGF2

Fibroblast growth factor 2 (basic)

BFGF, FGFB, HBGF-2

C04

HGF

Hepatocyte growth factor (hepapoietin
A; scatter factor)

DFNB39, F-TCF, HGFB, HPTA, SF

C05

IGF1

Insulin-like growth factor 1
(somatomedin C)

IGF-I, IGF1A, IGFI
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C06

IGF1R

Insulin-like growth factor 1 receptor

CD221, IGFIR, IGFR, JTK13, MGC142170,
MGC142172, MGC18216

C07

ILK

Integrin-linked kinase

DKFZp686F1765, ILK-2, P59

C08

ITGA4

Integrin, alpha 4 (antigen CD49D, alpha
4 subunit of VLA-4 receptor)

CD49D, IA4, MGC90518

C09

ITGB1

Integrin, beta 1 (fibronectin receptor,
beta polypeptide, antigen CD29
includes MDF2, MSK12)

CD29, FNRB, GPIIA, MDF2, MSK12, VLABETA, VLAB

C10

ITGB2

Integrin, beta 2 (complement
component 3 receptor 3 and 4 subunit)

CD18, LAD, LCAMB, LFA-1, MAC-1, MF17,
MFI7

C11

ITGB3

Integrin, beta 3 (platelet glycoprotein
IIIa, antigen CD61)

CD61, GP3A, GPIIIa

C12

LIMK1

LIM domain kinase 1

LIMK, LIMK-1

D01

MAPK1

Mitogen-activated protein kinase 1

ERK, ERK2, ERT1, MAPK2, P42MAPK,
PRKM1, PRKM2, p38, p40, p41, p41mapk

D02

MET

Met proto-oncogene (hepatocyte
growth factor receptor)

AUTS9, HGFR, RCCP2, c-Met

D03

MMP14

Matrix metallopeptidase 14
(membrane-inserted)

1, MMP-14, MMP-X1, MT-MMP, MT-MMP 1,
MT1-MMP, MT1MMP, MTMMP1

D04

MMP2

Matrix metallopeptidase 2 (gelatinase
A, 72kDa gelatinase, 72kDa type IV
collagenase)

CLG4, CLG4A, MMP-II, MONA, TBE-1

D05

MMP9

Matrix metallopeptidase 9 (gelatinase
B, 92kDa gelatinase, 92kDa type IV
collagenase)

CLG4B, GELB, MANDP2, MMP-9

D06

MSN

Moesin

-

D07

MYH10

Myosin, heavy chain 10, non-muscle

MGC134913, MGC134914, NMMHCB

D08

MYH9

Myosin, heavy chain 9, non-muscle

DFNA17, EPSTS, FTNS, MGC104539, MHA,
NMHC-II-A, NMMHCA

D09

MYL9

Myosin, light chain 9, regulatory

LC20, MGC3505, MLC2, MRLC1, MYRL2

D10

MYLK

Myosin light chain kinase

DKFZp686I10125, FLJ12216, KRP, MLCK,
MLCK1, MLCK108, MLCK210, MSTP083,
MYLK1, smMLCK

D11

PAK1

P21 protein (Cdc42/Rac)-activated
kinase 1

MGC130000, MGC130001, PAKalpha

D12

PAK4

P21 protein (Cdc42/Rac)-activated
kinase 4

-

E01

PFN1

Profilin 1

-

E02

PIK3CA

Phosphoinositide-3-kinase, catalytic,
alpha polypeptide

MGC142161, MGC142163, PI3K, p110-alpha

E03

PLAUR

Plasminogen activator, urokinase
receptor

CD87, U-PAR, UPAR, URKR

E04

PLCG1

Phospholipase C, gamma 1

NCKAP3, PLC-II, PLC1, PLC148,
PLCgamma1

E05

PLD1

Phospholipase D1,
phosphatidylcholine-specific

-

E06

PRKCA

Protein kinase C, alpha

AAG6, MGC129900, MGC129901, PKC-alpha,
PKCA, PRKACA

E07

PTEN

Phosphatase and tensin homolog

10q23del, BZS, DEC, GLM2, MGC11227,
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MHAM, MMAC1, PTEN1, TEP1
E08

PTK2

PTK2 protein tyrosine kinase 2

FADK, FAK, FAK1, FRNK, pp125FAK

E09

PTK2B

PTK2B protein tyrosine kinase 2 beta

CADTK, CAKB, FADK2, FAK2, PKB, PTK,
PYK2, RAFTK

E10

PTPN1

Protein tyrosine phosphatase, nonreceptor type 1

PTP1B

E11

PXN

Paxillin

FLJ16691

E12

RAC1

Ras-related C3 botulinum toxin
substrate 1 (rho family, small GTP
binding protein Rac1)

MGC111543, Rac-1, TC-25, p21-Rac1

F01

RAC2

Ras-related C3 botulinum toxin
substrate 2 (rho family, small GTP
binding protein Rac2)

EN-7, Gx, HSPC022

F02

RASA1

RAS p21 protein activator (GTPase
activating protein) 1

CM-AVM, CMAVM, DKFZp434N071, GAP,
PKWS, RASA, RASGAP, p120GAP,
p120RASGAP

F03

RDX

Radixin

DFNB24

F04

RHO

Rhodopsin

CSNBAD1, MGC138309, MGC138311, OPN2,
RP4

F05

RHOA

Ras homolog gene family, member A

ARH12, ARHA, RHO12, RHOH12

F06

RHOB

Ras homolog gene family, member B

ARH6, ARHB, MST081, MSTP081, RHOH6

F07

RHOC

Ras homolog gene family, member C

ARH9, ARHC, H9, MGC1448, MGC61427,
RHOH9

F08

RND3

Rho family GTPase 3

ARHE, Rho8, RhoE, memB

F09

ROCK1

Rho-associated, coiled-coil containing
protein kinase 1

MGC131603, MGC43611, P160ROCK,
PRO0435

F10

SH3PXD2A

SH3 and PX domains 2A

FISH, SH3MD1, TSK5

F11

SRC

V-src sarcoma (Schmidt-Ruppin A-2)
viral oncogene homolog (avian)

ASV, SRC1, c-SRC, p60-Src

F12

STAT3

Signal transducer and activator of
transcription 3 (acute-phase response
factor)

APRF, FLJ20882, HIES, MGC16063

G01

SVIL

Supervillin

DKFZp686A17191

G02

TGFB1

Transforming growth factor, beta 1

CED, DPD1, LAP, TGFB, TGFbeta

G03

TIMP2

TIMP metallopeptidase inhibitor 2

CSC-21K
ILWEQ, KIAA1027, TLN

G04

TLN1

Talin 1

G05

VASP

Vasodilator-stimulated phosphoprotein

-

G06

VCL

Vinculin

CMD1W, CMH15, MVCL

G07

VEGFA

Vascular endothelial growth factor A

MGC70609, MVCD1, VEGF, VPF

G08

VIM

Vimentin

FLJ36605

G09

WASF1

WAS protein family, member 1

FLJ31482, KIAA0269, SCAR1, WAVE,
WAVE1

G10

WASF2

WAS protein family, member 2

SCAR2, WAVE2, dJ393P12.2

G11

WASL

Wiskott-Aldrich syndrome-like

DKFZp779G0847, MGC48327, N-WASP,
NWASP

G12

WIPF1

WAS/WASL interacting protein family,
member 1

MGC111041, PRPL-2, WASPIP, WIP
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H01

ACTB

Actin, beta

PS1TP5BP1

H02

B2M

Beta-2-microglobulin

-

H03

GAPDH

Glyceraldehyde-3-phosphate
dehydrogenase

G3PD, GAPD, MGC88685

H04

HPRT1

Hypoxanthine
phosphoribosyltransferase 1

HGPRT, HPRT

H05

RPLP0

Ribosomal protein, large, P0

L10E, LP0, MGC111226, MGC88175, P0,
PRLP0, RPP0

H06

HGDC

Human Genomic DNA Contamination

HIGX1A

H07

RTC

Reverse Transcription Control

RTC

H08

RTC

Reverse Transcription Control

RTC

H09

RTC

Reverse Transcription Control

RTC

H10

PPC

Positive PCR Control

PPC

H11

PPC

Positive PCR Control

PPC

H12

PPC

Positive PCR Control

PPC

Table 2 - Topographical representation of the PCR Array Plate. The different extracellular matrix and
adhesion molecules present on the PCR Array Plate, their respective location on the plate, and a brief
description of the genes and other known names of the specific genes are indicated.
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Tat and the Cannabinoids CP55940 and THC do not alter the activation of RhoA in HL-60
Cells
The RhoA protein has two states, an activated GTP bound form, and an inactive
GDP bound form. The GTP bound form has been implicated in β-integrin and cytoskeletal
rearrangement and thus was chosen as a possible convergent point in the signal
transduction pathway (Palazzo et al., 2004) involving action mediated by extracellular Tat
in concert with the select cannabinoids CP55940 and THC (Fig. 5).
The first steps taken were to identify an optimal time point for Tat treatment where
the most activated form of RhoA could be observed. Therefore, once the macrophage-like
cells had been differentiated and had adhered to the human fibrinogen coated plates they
were treated with 50nM Tat for a time course ranging from 0 sec to 5 min (Fig. 23a). Since
these preliminary experiments indicated that it appeared that the optimal time point was
most likely outside of the 5 min window, longer treatment conditions were applied and Tat
treatments were observed over a 30 min window (Fig. 23b). These experiments indicated
that optimal Tat treatment time points for eliciting the highest expression of RhoA were 15
min and 30 min.
Based on these observations, treatments of vehicle, Tat, cannabinoids, and Tat +
cannabinoids were performed at 15 min and 30 min to assess for RhoA activation. First,
the total level of RhoA protein was observed using western immunoblotting (Fig. 24a) and
then a “pull-down” assay was performed using the Rhotekin Binding Domain (RBD) kit
that utilizes beads that will pull down only the active, GTP bound, form of RhoA (Fig.
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24b). The beads containing the RBD domain were divided into 30µg and then HL-60
lysate samples were washed over the beads for one hour. Residual protein was then washed
away and the remaining activated (GTP –bound) RhoA was detected using western
immunoblotting. No significant differences were observed in the active GTP bound RhoA
under any of the treatment conditions.
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Figure 23- Western immunoblot of HL-60 cells differentiated over 4 days using all-trans-retinoic acid
(ATRA) and allowed to adhere to human fibrinogen coated plate. Cells were treated with Vehicle
(Sodium Citrate + 0.01% ethanol) or 50nM Tat for a range of (a). 60s to 300s and (b). 5m to 30m.
Lysates were prepared using a lysis buffer provided by Cytoskeleton® and prepared following their
protocol. Anti-RhoA antibodies were used to detect levels of RhoA (Cytoskeleton #ARH03-A). α-Actin
was used as a control for proper loading of each lane with equal concentrations of protein. A positive
control of RPMI-1640 containing serum was utilized according to Cytoskeleton.
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Figure 24- Western immunoblot of HL-60 cells differentiated over 4 days using all-trans-retinoic acid
(ATRA) and allowed to adhere to a human fibrinogen coated plate. Cells were treated with Vehicle
(Sodium Citrate + 0.01% ethanol), 50nM Tat, 10-6M CP55940/THC, or 50nM Tat + 10-6M
CP55940/THC for either 15m or 30m. Lysates were prepared using a lysis buffer provided by
Cytoskeleton® and prepared following their protocol. Anti-RhoA antibodies were used to detect levels
of RhoA (Cytoskeleton #ARH03-A).
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Discussion

Since the advent of HAART survival rates of patients infected with HIV-1 have
increased. However, this increase in survival is tempered by the development of HIVAssociated Neurocognitive Disorders (HAND). The CNS is invaded by the transmigration
of leukocytes that act as viral reservoirs and migrate across the blood-brain barrier (BBB)
(Buckner et al., 2006). Acting as viral reservoirs, infected macrophage-like cells secrete a
broad range of molecules from chemokines and cytokines to toxic viral proteins such as
HIV glycoprotein 120 (gp120) and Tat. These HIV-associated events lead to increased
inflammation in the brain as a consequence of deregulation of immunocytes and
compromise of the BBB contributing to increased entry of infected as well as uninfected
activated leukocytes.
Extracellular Tat protein has been shown to alter adhesion and cell morphology of
monocytes and macrophages to the endothelium as well as the ECM (Matzen et al., 2004;
Barillari et al., 1993). Specifically, Tat has been implicated in the invasion of monocytes
into reconstituted basement membranes of the ECM as well as increasing their adhesion to
endothelial monolayers (Lafrenie et al., 1996). Similarly, an increase in Tat levels has
been shown to occur synergistically with TNFα resulting in increased adhesion to
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endothelial cells both in vitro and in vivo (Matzen et al., 2004). Even though infected
monocytes/macrophages are the predominate HIV positive cells located in the brain, the
mechanism for their entry into the CNS is poorly understood. While HIV-1 Tat has been
shown to increase adherence of monocytes to endothelial cells as well as the ECM, select
cannabinoids such as THC and CP55940 have been shown to decrease adherence and
invasion of monocytes in a mode that is linked functionally to the CB2R (Rajesh et al.,
2007; Ramirez et al., 2012). The recognition that such immune modulation uses the CB2R
as a molecular target has emerged as a potential way to treat neurocognitive disorders as
well as modulate immune system function (Cabral & Griffin-Thomas, 2009; Klein, 2005).
It has been shown that extracellular Tat increases expression of adhesion molecules
of macrophage-like cells thus enhancing monocyte-adhesion as well as monocyteendothelium interactions (Lafrenie et al., 1996) while cannabinoids inhibit these effects
(Raborn et al., 2012). Based on this information initial microscopy studies were performed
in order to gain further insight regarding adherence and cytoskeletal rearrangement taking
place when Tat-treated cells are allowed to adhere to different ECM components (Raborn
et al., 2013). By confocal microscopy it was possible to observe morphological changes
and rearrangement in β-integrin as well as actin polymerization in macrophage-like cells.
Both U937 and HL-60 cells are human myelogenous leukemia-derived cell lines that can
be differentiated in vitro by chemical agents and thus are often used as models to study the
terminal differentiation of myelomonocytic cells. It was observed that rearrangement of
cytoskeletal elements occurred in HL-60 cells that was accompanied by increased
adherence to the ECM, similar to the U937 cell line, suggesting that the attachment process
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resulted in signal transduction activation of these cells and that such activation occurred
early in the adhesion process. Based on results early events in the signal transduction
cascades that could be linked to cytoskeletal rearrangement were investigated.
Adhesion molecules play a key role in the invasion of monocytes/macrophages
from the peripheral circulation into tissue. The movement of monocytes/macrophages from
peripheral circulation into tissue occurs in three separate phases involving different
adhesion molecules. First, P-selectins initiate early adhesion as leukocytes are “rolling”
through the circulatory system. Next, when these leukocytes are exposed to activating
agents such as chemoattractants or phorbol 12-myristate-13-acetate (PMA), they become
extremely adhesive to the endothelium. This interaction involving the endothelium and the
leukocytes, appears to mediate the activation of β2-integrins resulting in increased
adhesion, cytoskeletal rearrangement, and “spreading” of the leukocytes (Kuijpers et al.,
1990; Lo et al., 1989). However, the molecular nature for this change in β-intergrin affinity
is unknown, although their increased adhesiveness is well documented (Springer, 1994).
Once these integrins are activated, there is a greater interaction with endothelial
intercellular adhesion molecules (ICAMs) and vascular cellular adhesion molecules
(VCAMs) leading to more robust adhesion of the leukocytes. Finally, once the integrins
are activated they enable strong adhesion of the cell to the endothelium allowing
diapedisis, the movement of blood cells from peripheral circulation into the body tissue, to
occur and invasion of the leukocytes to take place.
The effects of Tat on adhesion and infiltration of monocytes is well documented,
specifically with regard to inflammatory processes and adhesion. Moreover, Tat has been
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shown to regulate intracellular adhesion molecules (ICAMs) and vascular cell adhesion
molecules (VCAMs) as well as the integrin family of proteins. Similarly, Tat has been
shown to up-regulate the expression of β2-integrein adhesion molecules as well as
increasing monocyte adhesion (Lafrenie et al., 1996; Lafrenie et al., 1996; Lafrenie et al.,
1997). HIV-1 Tat has also been shown to increase leukocyte adhesion to the endothelium
in vivo (Matzen et al., 2004). Integrins act as receptors capable of creating biochemical
signals that act through secondary messengers within the cell. Many of these secondary
messengers and pathways are well documented (reviewed in (Rosales et al., 1995), and
these signaling events warrant future research. Specifically, a connection between integrin
activated gene induction and tyrosine phosphorylation has been demonstrated (Lin et al.,
1994b). Since there is a cascade of tyrosine phosphorylation between integrin gene
induction and integrin-mediated adhesion, it is worth looking at downstream elements in
the integrin signal transduction pathway. Specific pathways implicated in Tat activation
are ERK and JNK MAP kinases (Ganju et al., 1998; Gu et al., 2001) that control cell fate
decisions of monocytes as they adhere and undergo diapedesis. Also, Tat has been shown
to cause actin rearrangement through activation of Ste20 kinase p21/cdc 42/Rac-activated
kinase (PAK). The principal activators of PAK1, Rac1, and Cdc42 are members of the Rho
GTPase family (Wu et al., 2007).
It is well documented that Tat enhances adhesion and inflammatory processes in
monocytes through signal transduction cascades involving integrins. Specifically Tat
signal transduction is primarily pro-inflammatory causing increased invasion, as well as
cytokine and chemokine production. Select cannabinoids have been reported to decrease
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the presence of these adhesion molecules (Rajesh et al., 2007; Ramirez et al., 2012; Pu et
al., 2003). While Tat has been shown to increase adhesion of monocytes to the
endothelium as well as the production of pro-inflammatory molecules, treatment with
cannabinoids that act through the CB2R has resulted in a decrease in adhesion and
invasion of monocytes as well as decreasing the production of pro-inflammatory molecules
(Rajesh et al., 2007; Ramirez et al., 2012). More specifically, cannabinoid receptors
produce signals that regulate nuclear DNA binding factors through a cAMP-independent
MAP kinase pathway that is used for regulation of gene transcription (Berdyshev, 2000).
Several other molecules have been reported to be involved in CB2R signaling, including
phosphatidylinositol 3-kinase (PI3K), and members of the mitogen-activated protein
kinase NF-kB families, which are involved in the anti-inflammatory events, associated
with cannabinoids (Kurihara et al., 2006).
Both Tat and cannabinoids have been implicated in modulating cell signaling in a
variety of ways that include involvement of adhesion and invasion as well as cytokine and
chemokine production. Specifically, since cannabinoids that bind the CB2R act as antiinflammatory agents through signal transduction cascades cannabinoids appear to have
viable potential in reducing Tat-associated inflammation through signal transduction
events. One of the most well studied signal transduction pathways involving Tat and
cannabinoids is the integrin signal transduction pathway. The specific signal transduction
cascade involving integrin receptors begins when ligands bind to the extracellular domain
of integrins causing changes in their conformation resulting in clustering. Then since
integrins lack kinase activity they utilize secondary messenger tyrosine kinases.
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Specifically FAK is phosphorylated at Tyr-397 once ligand binding occurs followed by
activation of a Rho GTPase resulting in modulation of phosphorylation of the myosin light
chain (MLC) as well as the ERM family. These molecules then go on to modulate stress
fiber formation as well as actin contraction. Several molecules of this pathway have been
examined including Rac, Ras, ERK, MAPK, Rho, FAK as well as many other signal
transduction molecules. Based on the microscopy involving β-integrin reorganization as
well as actin polymerization it seemed plausible to conclude that there was a convergent
point along one of these two signal transduction cascades linked to the effects of
extracellular Tat protein and the cannabinoids THC and CP55940.
In order to assess some of the possible signal transduction cascades that could be
implicated in this cytoskeletal rearrangement and to identify candidate pathways, several
high-throughput methods were employed. The first approach entailed the use of a proof-ofprinciple Tyrosine Kinase (TK) phosphorylation array, which examined 71 different
human TKs and their phosphorylation. Tyrosine kinases are important regulators of
intracellular signal transduction pathways as well as mediators of multicellular
communications (Adachi et al., 2007). There are two major types of tyrosine kinases,
receptor tyrosine kinases (RTKs) and non-receptor protein tyrosine kinases (PTKs). PTKs
constitute a large family of different molecules including Src, Janus kinases (Jaks) and Abl
along with others. The Src family of kinases (SFKs) is the largest and plays an important
role in signaling in a variety of different cell types. When different stimuli activate surface
receptors they stimulate SFKs that transduce signals to different downstream signaling
factors. Among several of the SFKs are Lck, Lyn, Hck, Fgr, and Blk, along with others
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(Adachi & Suzuki, 2007). The kit employed for this study allowed for monitoring of
different TKs via phosphorylation as a means to implicate a specified signaling pathway as
linked to cytoskeletal rearrangement. Since there are numerous pathways involved in cell
adhesion, this kit served as a tool for a starting point to look at multiple molecules in order
to gain insight regarding an involved pathway. One of the key pathways examined was the
β-integrin pathway that is involved in cell adhesion to the ECM.
The membranes were treated with 50nM Tat protein at both 10 and 20 min in order
to find the optimal time point for TK phosphorylation. The concentration of 50nM was
chosen based on previous studies performed in the laboratory (Fraga et al., 2011). Once the
optimal time point was determined, the effects of THC and CP55940 were observed. Again
concentrations of 10-6M of both THC and CP55940 were used. The TKs Fgr, Pyk2,
SRMS, Syk, and TXK were shown because they displayed an increased level of
phosphorylation consistent with their activation by Tat. These molecules also showed a
decreased level of Tat-engendered phosphorylation upon treatment with THC and
CP55940 + Tat, consistent with involvement of a signal transduction pathway in the
cannabinoid-mediated effect on adhesion to cytoskeletal elements. Based on these data, the
β-integrin pathway seemed like the most promising target point to examine as modulation
by select cannabinoids was observed for FAK a non-receptor tyrosine kinase involved in
the β-integrin pathway as well as Pyk2 which is a proline-rich homologue to FAK (Recher
et al., 2004).
While FAK and Pyk2 share many characteristics, they also exhibit key differences.
FAK signals for both PI3K and MAPK that are involved in cell motility; however, Pyk2
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can display a proapoptotic function resulting in apoptosis due to exposure to certain drugs
or cytokines (Recher et al., 2004). It has been documented that FAK is weakly expressed
in murine immature myeloid precurosors (Kume et al., 1997). Similarly, FAK is expressed
in leukocytes, but not in macrophages (Denichilo et al., 1993; Levesque et al., 1999;
Fuortes et al., 1994). While FAK and Pyk2 share a 45% overall sequence similarity FAK
phosphorylation occurs at six sites while only four of these sites are present in Pyk2.
However, the major role of signal transduction involving the Src family kinases (SFKs)
remains the same. Additionally Pyk2 is not only regulated by phosphorylation, but also by
calcium signaling. Finally, while FAK is localized in focal adhesion-plaques, Pyk2 can be
found in the perinuclear areas (Nakamura et al., 2001).
Additionally, modulation was seen in Fgr, a non-receptor tyrosine kinase that is a
member of the Src family kinases involved in β-integrin signaling. Further analysis of the
different molecules affected by Tat and select cannabinoids is required in order to isolate
signal transduction molecules specifically involved in cytoskeletal rearrangements that are
targeted by cannabinoids.
Next, a proof-of-principle human cell motility RT-PCR array plates were used as a
high-throughput method to identify a specific signal transduction pathway implicated in
the cytoskeletal rearrangement of macrophage-like cells caused by the interaction of Tat
and THC or CP55940. Specifically, the levels of mRNAs for select molecules involved in
human cell motility were assessed under given experimental conditions. The plate used
allowed for the identification of mRNAs from 84 genes involved in the movement of cells
including actin rearrangement as well as cytoskeleton mobilization. A time point of 8h was
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chosen for assessment of effects based on previous studies that were performed in the
laboratory in which rat primary microglial cells were used (Puffenbarger et al., 2000). Each
dot on the scatter plot represents one of the 84 key genes linked to the movement of the
cells. The dots are distributed along the line indicating no change in mRNA expression
according to their different levels represented in logarithmic form. These different
expression levels are also standardized to housekeeping genes present on the RT-PCR
plate.
Based on the RT-PCR mRNA expression analysis no statistical differences were
observed in any of the genes on the array. This was not surprising as cytoskeletal
rearrangements such as actin polymerization and β-integrin expression levels are transient
events. Thus, had the mRNA levels under the given experimental conditions been read at
multiple time points along the 8h window it would have been far more likely that the
expression level of the mRNA for specific genes involved in cytoskeletal rearrangement
and mobility could have changed. Another possible explanation for the absence of
response is that the Tat protein used was from a T-lymphocyte-tropic strain (IIIB). There is
another Tat protein available from a monotropic strain (BAL) as well as a dual-tropic
strain. Given that the HL-60 cells are of myeloid origin it is possible that a BAL Tat would
engender a more robust response. Further analysis would need to be done in order to show
this however.
Work was then begun to characterize the regulatory molecules involved in the βintegrin signal transduction pathway. While the mechanism by which HIV alters monocyte
gene expression remains unknown it has been shown that treatment of monocytes with
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extracellular Tat changes β1-integrin expression levels (Lafrenie et al., 1996). Our work
with cellular staining and visualization of β1-integrin expression yielded similar results.
However, it has been shown that pre-treatment of cells with THC and CP55940 reduces
this increased expression of β1-integrin presenting, a putative signal transduction pathway
convergent point for signal transductional activities linked to the interaction of
extracellular Tat and select cannabinoids. Therefore, it is thought that along this β1-integrin
signal transduction pathway involving adhesion there is a putative convergent point at
which both extracellular Tat protein and THC or CP55940 acts.
One of the key molecules associated with adhesion and migration is focal adhesion
kinase (FAK). FAK is a non-receptor tyrosine kinase that localizes to regions of the cell
that attach to the ECM. Specifically FAK will coordinate signals from integrins as well as
growth factors to localize and adhere to the ECM. FAK is involved in
autophosphorylation, and one of the major sites of this is Tyr-397 (Recher et al., 2004).
The phosphorylation at Tyr-397 is necessary for Src binding to FAK which is an essential
step in promoting cell migration (Cary et al., 1996). Similarly, activation of integrins that
occurs when cells bind to the ECM leads to an increase in FAK tyrosine phosphorylation
(Guan et al., 1991; Kornberg et al., 1991; Burridge et al., 1992). Therefore, FAK
phosphorylation at Tyr-397 was observed under different experimental conditions using
western immunoblot analysis in triplicate to determine whether the focal adhesion
molecules were involved in an interaction between extracellular Tat and THC or CP55940.
Following differentiation of HL-60 cells into macrophage-like cells assessment of
phosphorylation at Tyr-397 was undertaken in order to determine whether integrin
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activation lead to ECM binding. Differential time points were used in order to determine
the optimal time point for Tat treatment before treating with Tat and in concert with THC
or CP55940. However, problems arose in that the focal adhesion kinase was a difficult
protein to isolate and thus levels of phosphorylation were difficult to determine. No
statistical differences were seen between vehicle-treated cells when compared to Tattreated cells when observing phosphorylation of FAK. Increases in phosphorylation were
observed at the 5 and 10 minute time points in both Tat and vehicle-treated cells, most
likely due to the fact that sodium citrate can act as an activating agent. Later it was found
that FAK is weakly expressed in monocytes/macrophages (Choi et al., 1993; Denichilo &
Burns, 1993; Yamada et al., 1997; Lin et al., 1994a; Roach et al., 1997) suggesting that the
action of FAK might be carried out by Pyk2. This is because Pyk2 is a molecule that is
highly expressed in monocytes and macrophages (Hatch et al., 1998). Therefore it is most
likely that had the western immunoblot analysis been done for Pyk2 as opposed to focal
adhesion kinase better results would have been obtained.
While integrins lack intrinsic tyrosine kinase activity there are signaling events
involved in their clustering and adhesion to the ECM. One of the early events in integrin
signaling is the phosphorylation of focal adhesion kinase mentioned above (Kumar, 1998).
This phosphorylation will, in turn, lead to the activation of the GTPase RhoA (Palazzo et
al., 2004). Through such events in the signal transduction cascade integrins are able to
mediate the adhesion and spreading of specific cells to the ECM (Barillari et al., 1999a). It
has been shown that once FAK phosphorylation takes place numerous secondary
messengers are then activated, including that of RhoA (Urbinati et al., 2005). This
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activation of RhoA does not occur solely through the β-integrin pathway but is still a major
step in the pathway.
One of the difficulties in observing the RhoA protein is that the cognate antibody
will bind both the active and inactive forms of RhoA. Thus it is necessary to use beads for
the Rhotekin Binding Domain (RBD) to pull down the active, GTP bound, form of RhoA.
Upon treatment of macrophage-like cells with Tat, cannabinoids (i.e. THC or CP55940),
and Tat + cannabinoids both total RhoA protein and the active GTP bound RhoA were
observed. Based on experiments performed previously using HL-60 cells and cannabinoids
that act through the CB2R, human fibrinogen was used as a coating medium to allow for
macrophage adherence. It has been shown that RhoA activation levels decrease in HL-60
cells when the cells are differentiated into macrophage-like cells and attached to human
fibrongen (Kurihara et al., 2006).
Based on the previous work done on HL-60 cells and RhoA using the CB2R the
conditions were replicated for a proof-of-principle experiment by coating plates with
human fibrinogen and treating with Tat, cannabinoids, and Tat + cannabinoids. There was
no statistical difference obtained in levels of total RhoA protein when cells were
maintained in the presence or absence of Tat and/or THC or CP55940. However, the level
of total RhoA protein was decreased when the Tat + THC or CP55940 treated cells were
observed via western immunoblotting.
To check whether this decrease was caused by modulation of the active, GTP
bound, form of RhoA a pull down assay was conducted using the Rhotekin Binding
Domain (RBD), which is a domain that only binds the active GTP bound form of RhoA.
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After detecting the active GTP bound form of RhoA, it was determined that there was no
statistical difference in the amount of RhoA-GTP bound protein present under the given
treatment conditions. Thus, there was a significant decrease in the total RhoA protein
under Tat + cannabinoid treatment conditions but no difference in the active GTP bound
form under these same conditions.
Based on the observations of total RhoA compared to GTP bound RhoA it is most
likely that under the Tat + cannabinoid treatment conditions there is some sort of RhoA
degradation. It does not appear that any degradation of the RhoA protein is under the Tat
and cannabinoid treatment conditions. Therefore, in order to further investigate these
findings the experiment needs to be repeated in order to show reproducibility. Upon
successful reproduction of the same results it is probable that the RhoA molecule is being
sequestered or there is some sort of cross talk between molecules involving RhoA. In order
to resolve this event confocal microscopy could be used under the given treatment
conditions to observe the sequestration of the RhoA protein into a different compartment
under the Tat + cannabinoid treatment conditions.
Further work needs to be conducted starting with the repetition and investigation of
the possible sequestration of the RhoA under the Tat and cannabinoid treatment conditions.
Confocal microscopy can be used in order to determine whether this molecule is being
relocated under these conditions. Similarly since monocytes/macrophages do not express
FAK well it is also important to further investigate the expression levels of the homolog
Pyk2. This molecule has strong similarity to FAK and could serve as a convergent point
along the β-integrin signal transduction cascade since they both act on RhoA. While it is
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highly probable that this putative convergent point exists somewhere along a signal
transduction cascade a definitive answer has not yet been resolved but some novel insight
into which pathways to look at and what molecules may be implicated has been
established. Similarly, while it is probable that the CB2R is being induced there is no direct
evidence that has yet been obtained that indicates a functional linkage to any signal
transductional pathway that is involved in cell motility. Specific agonists and antagonists
of the CB2R could be utilized as well as knockouts and siRNA to resolve the involvement
of the CB2R in this process.
In summary, the first goal of this study was to determine if Tat-enhanced
attachment to an extracellular matrix substrate was affected by cannabinoids. Confocal
microscopy and SEM demonstrated that Tat-enhanced adhesion to an ECM substrate was
inhibited by the cannabinoids THC or CP55940. The second goal was to determine if this
Tat-enhanced attachment activated a signal transductional pathway, and that such
activation was affected by the cannabinoids THC and CP55940. Although several signal
transductional pathways were shown to be activated by Tat, a definitive role of
cannabinoids and their modulation remains to be defined. Similarly whether a cannabinoid
receptor is linked functionally to the inhibition of adhesion to an ECM component remains
to be defined.
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